• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Serum alpha_1-microglobulin variations in acute reaction phase

Research Project

Project/Area Number 05671929
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Laboratory medicine
Research InstitutionJichi Medical School

Principal Investigator

KAWAI Tadashi  Jichi Medical School, Clinical Pathology, Professor, 医学部, 教授 (60048957)

Co-Investigator(Kenkyū-buntansha) ITOH Yoshihisa  Jichi Medical School, Clinical Pathology, Assosiate professor, 医学部, 助教授 (20129026)
高 余洲  自治医科大学, 医学部, 助手 (30234686)
Project Period (FY) 1993 – 1994
Project Status Completed (Fiscal Year 1994)
Budget Amount *help
¥1,800,000 (Direct Cost: ¥1,800,000)
Fiscal Year 1994: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 1993: ¥900,000 (Direct Cost: ¥900,000)
Keywordsalpha_1-microglobulin / Interleukin 6 / IgA / Amyloid A / alpha-chain disease / alpha_1-マイクログロブリン / SAA / CRP / IL-6 / 肝硬変症
Research Abstract

alpha1-microglobulin (alpha1-m) is a low molecular weight glycoportein of 30kDa synthesized at liver as most of proteins are. Serum variations of this protein were investigated both in patients with surgical operation and alpha-chain disease.
2) alpha1-microglobulin clinically proved to be a positive acute phase reactant. Serum value was ellvated postoperatively depending on the synthetic capacity of the liver reserved. Since its molecular weight was low, it is easily cleared from kidney, that have so far made it impossible to define this protein as a acute phase reactant. Futrher fundamental study is under way to elucidate precise mechanisms of alpha1-m reaction at the liver.
For clinical significance, total measurement of this protein can be useful as a sensitive indicator of liver function and its recovery.
2) Structure analysis of an alpha-chain-alpha1-m complex in alpha-chain disease
Basic structure of alpha-chain-alpha1-m complex is a heterodimer of Fcalpha and Fcalpha-alpha1-m complex, in latter of which alpha1-m covalently binds at 1 : 1 molar ratio. alpha1-m was extremely low in serum concentration as compared with that in alpha-chain.
Immunohistochemical examinations have shown no alpha1-m positive localization in involved tissues, but structurally abnormal alpha-chain. A complex form should be synthesized elsewhere in the tissues in the body once alpha-chain is released into circulation from involved lymph nodes.
3) Development of a serum amyloid A (SAA) assay
In the process of the present study, a precise assay for SAA was developed using a latex agglutination reaction.
4) Mechanisms of alpha1-m synthesis
Effects of Interleukin 6 was investigated on synthetic capacity of alpha1-m by a hepatoma cell line (cCH4) to show that the alpha1-m was reduced in its value in the supernatant fluids, which contradicted the clinical findings.

Report

(3 results)
  • 1994 Annual Research Report   Final Research Report Summary
  • 1993 Annual Research Report
  • Research Products

    (3 results)

All Other

All Publications (3 results)

  • [Publications] 佐々木勝一他: "ラテックス凝集反応法を用いた血清アミロイドAの基礎的検討"

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] K.Sasaki, Y.Itoh, T.Kawai.: "A latex agglutination assay for serum amyloid A" IGAKU TO YAKUGAKU. (in press). (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] 佐々木勝一: "ラテックス凝集反応法を用いた血清アミロイドAの基礎的検討" 薬学と医学. (in press). (1995)

    • Related Report
      1994 Annual Research Report

URL: 

Published: 1993-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi